Showing results (291-300 of 302) with videos related to

Sort By:
Pageof 31
The Journal of Clinical Investigation|December 17, 2020
Inhibition of 2-hydroxyglutarate elicits metabolic reprogramming and mutant IDH1 glioma immunity in micePadma Kadiyala, Stephen V Carney, Jessica C Gauss, et al.
Molecular Therapy. Oncology|May 22, 2026
Reprogramming the immune suppressive tumor microenvironment in glioma enhances the efficacy of immune-mediated gene therapyBrandon L McClellan, Jorge A Peña Agudelo, Anzar A Mujeeb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2023
Zinc Finger MYND-Type Containing 8 (ZMYND8) Is Epigenetically Regulated in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma to Promote RadioresistanceStephen V Carney, Kaushik Banerjee, Anzar Mujeeb, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Reprogramming the Immune Suppressive Tumor Microenvironment in Glioma Enhances the Efficacy of Immune-Mediated Gene TherapyBrandon L McClellan, Jorge A Peña Agudelo, Anzar A Mujeeb, et al.
Science (New York, N.Y.)|May 7, 2026
Intermetallic nanoassemblies potentiate systemic STING activationXingwu Zhou, Xiang Ling, Xiaoqi Sun, et al.
ACS Nano|May 20, 2024
Mechanisms and Barriers in Nanomedicine: Progress in the Field and Future DirectionsThomas Anchordoquy, Natalie Artzi, Irina V Balyasnikova, et al.
Ophthalmology. Retina|June 12, 2022
The Prevalence of Retinal Disease and Associated CNS Disease in Young Patients with Incontinentia PigmentiIan D Danford, Brittni A Scruggs, Antonio Capone, et al.
AAPS Open|April 23, 2026
Mastering particle size analysis: lessons, challenges, and future directions from the FDA-CRCG workshopXiaoming Xu, William C Smith, James E Polli, et al.
Pageof 31